(NASDAQ: GNFT) Genfit Sa's forecast annual revenue growth rate of 23.22% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.06%.
Genfit Sa's revenue in 2024 is $41,495,652.On average, 2 Wall Street analysts forecast GNFT's revenue for 2024 to be $5,158,419,090, with the lowest GNFT revenue forecast at $4,937,650,116, and the highest GNFT revenue forecast at $5,379,188,065. On average, 2 Wall Street analysts forecast GNFT's revenue for 2025 to be $2,825,892,711, with the lowest GNFT revenue forecast at $2,009,844,864, and the highest GNFT revenue forecast at $3,641,940,558.
In 2026, GNFT is forecast to generate $4,543,953,750 in revenue, with the lowest revenue forecast at $4,123,844,843 and the highest revenue forecast at $4,964,062,657.